IHS Chemical Week

World News and Views :: Top of the News

Genomatica Raises $41.5 Million, Withdraws IPO

6:43 AM MDT | August 2, 2012 | Rebecca Coons

Biobased technology company Genomatica (San Diego) announced today that it has raised $41.5 million in a Series D financing round, which includes new investor and partner Versalis, and it will withdraw its registration for a public offering. The funding will enable Genomatica to accelerate commercialization of its 1,4-butanediol production platform and expand its product pipeline into other biochemicals, including butadiene, CEO and founder Christophe Schilling tells CW. Schilling also said that, after evaluating all financing options, the company determined that...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa